Philips has launched the IntraSight Plus coronary interventions platform, which is cleared for clinical use in Europe and the US.The...
C4 Therapeutics has begun dosing in a Phase Ib study assessing cemsidomide and Elrexfio in patients with relapsed or refractory...
Daiichi Sankyo has collaborated with Tempus AI to expedite the clinical development and differentiation of an ADC programme in oncology.The...
Neurovalens has received the EU Medical Device Regulation (MDR) compliance for its prescribed insomnia device, Modius Sleep.The post Neurovalens receives...
IASO Biotechnology has received CTN clearance from Japan PMDA to begin a Phase III study of equecabtagene autoleucel cell therapy...
MSD has signed a multi-year research collaboration with Quotient Therapeutics to discover new drug targets for IBD.The post MSD and...
Samsung Medison has unified its medical imaging entities, formerly NeuroLogica and Boston Imaging, under the new identity, Samsung HME America.The...
Sensorion has reported a six-month update from the Audiogene Phase I/II clinical trial’s cohort 2 assessing SENS-501, its gene therapy...
Sanofi and Kali Therapeutics have signed an exclusive global licence agreement for KT501, a new tri-specific antibody for B cell-mediated...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.